Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN Symposium 2018 /
Lessons from long-term survey of stage I NSCLC

25th - 26th Jun 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.07.18
Views: 774

Prof Harvey Pass - New York University Langone Medical Center, New York, USA

Prof Pass speaks with ecancer at the 2018 WIN symposium about the BOOSTER trial and his role in its design.

He describes the kind of things they will be looking for the samples collected during the BOOSTER trial and how this will be useful.

Prof Pass also emphasies the importance of sub-categorisation through the study design.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation